Evidence map›Paper›PMID 41806020›Full record

ArticleAbdominal radiology (New York)2026

Diagnostic value of [

Xiaolin Chen, Mengjiao Wang, Yan Zhao, Yuhan Sun, Bin Guo, Xiao Pang, Meng Dai, Xiujuan Zhao, Ting Zhang, Xiaoshan Chen and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaolin ChenDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Mengjiao WangDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Yan ZhaoDepartment of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Yuhan SunDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Bin GuoDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Xiao PangDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Meng DaiDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Xiujuan ZhaoDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Ting ZhangDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China.
Xiaoshan ChenDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China. 22032100140@stu.hebmu.edu.cn.
Xinming ZhaoDepartment of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, China. xinmingzhao@hebmu.edu.cn.

Funding

Hebei Medicine-Research-Enterprise Collaborative Innovation Project LH20250166Medical Science Research Project of Hebei No. 20230917the Foundation of the Hebei Provincial Department of Education Degree Office Graduate Innovation Funding Project for Higher Education Institutions No. CXZZBS2025108
6 · The paper itself

Abstract

purposePeritoneal carcinomatosis (PC) carries a poor prognosis, making accurate imaging vital for patient selection and treatment optimization. This study aims to evaluate [

methodsIn this retrospective study, 267 patients (99 males; median age 59 years) suspected of peritoneal malignancies underwent [

resultsOf the 267 patients, 251 were confirmed to have peritoneal metastasis. On patient-based versus lesion-based analysis, the modality achieved a sensitivity of 98.8% (248/251) vs. 93.8% (180/192); a specificity of 50% (8/16) vs. 72.7% (8/11); and an accuracy of 95.9% (256/267) vs. 92.6% (188/203). Compared with surgical pathology, [

conclusions[

Indexed as

CarcinomaOligopeptidesPeritoneal NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleGallium RadioisotopesHumansMaleMiddle AgedQuinolinesRadiopharmaceuticalsRetrospective StudiesSensitivity and Specificity68Ga-FAPIGallium RadioisotopesOligopeptidesQuinolinesRadiopharmaceuticals[68Ga]Ga-FAPI-04Peritoneal cancer indexPeritoneal carcinomatosisPET/CTSurgical pathology

Identifiers

PMID41806020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.